Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/742
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFazil Marickar, Y M-
dc.contributor.authorSylaja, N-
dc.contributor.authorPeter Koshy-
dc.date.accessioned2013-11-13T08:44:41Z-
dc.date.available2013-11-13T08:44:41Z-
dc.date.issued2009-
dc.identifier.citationUrological Research 37(5):299-303;Oct 2009en_US
dc.identifier.issn0300-5623-
dc.identifier.urihttp://ir.niist.res.in:8080/jspui/handle/123456789/742-
dc.description.abstractSeveral plant preparations are administered for treatment of stone disease without scientific basis. This paper presents the results of in vitro and animal experimental studies using scanning electron microscopy (SEM) in the identification of the therapeutic properties of trial drugs in medicine. In the first set of the study, urinary crystals namely calcium oxalate monohydrate and calcium oxalate dehydrate were grown in six sets of Hane's tubes in silica gel medium. Trial drugs namely scoparia dulcis Lynn, musa sapiens and dolicos biflorus were incorporated in the gel medium to identify the dopant effect of the trial drugs on the size and extent of crystal column growth. The changes in morphology of crystals were studied using SEM. In the second set, six male Wistar rats each were calculogenised by administering sodium oxalate and ethylene glycol and diabetised using streptozotocin. The SEM changes of calculogenisation were studied. The rats were administered trial drugs before calculogenisation or after. The kidneys of the rats studied under the scanning electron microscope showed changes in tissue morphology and crystal deposition produced by calculogenisation and alterations produced by addition of trial drugs. The trial drugs produced changes in the pattern of crystal growth and in the crystal morphology of both calcium oxalate monohydrate and calcium oxalate dihydrate grown in vitro. Elemental distribution analysis showed that the crystal purity was not altered by the trial drugs. Scoparia dulcis Lynn was found to be the most effective anticalculogenic agent. Musa sapiens and dolicos biflorus were found to have no significant effect in inhibiting crystal growth. The kidneys of rats on calculogenisation showed different grades of crystals in the glomerulus and interstitial tissues, extrusion of the crystals into the tubular lumen, collodisation and tissue inflammatory cell infiltration. Scoparia dulcis Lynn exhibited maximum protector effect against the changes of calculogenisation. Musa sapiens and dolicos biflorus had only minimal effect in preventing crystal deposition, inflammatory cell infiltration and other changes of calculogenisation. SEM was found to be effective in assessing the effect of drugs on crystal growth morphology and tissue histology.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.subjectCrystal growthen_US
dc.subjectScoparia dulcis Lynnen_US
dc.subjectMusa sapiensen_US
dc.subjectDolicos biflorusen_US
dc.subjectCalculogenisationen_US
dc.subjectCalcium- oxalate nephrolithiasisen_US
dc.subjectStone formersen_US
dc.subjectUrinary stoneen_US
dc.titleRole of scanning electron microscopy in identifying drugs used in medical practiceen_US
dc.typeArticleen_US
Appears in Collections:2009

Files in This Item:
File Description SizeFormat 
2009 _ 00026.pdf
  Restricted Access
423.79 kBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.